메뉴 건너뛰기




Volumn 235, Issue 3, 2015, Pages 490-501

Golgi phosphoprotein 3 (GOLPH3) promotes hepatocellular carcinoma cell aggressiveness by activating the NF-κB pathway

Author keywords

Biomarker; GOLPH3; Hcc progression; Nf b pathway; Ubiquitination

Indexed keywords

CISPLATIN; GOLGI PHOSPHOPROTEIN 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; PHOSPHOPROTEIN; RECEPTOR INTERACTING PROTEIN; TUMOR MARKER; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; UNCLASSIFIED DRUG; GOLPH3 PROTEIN, HUMAN;

EID: 84920722356     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4479     Document Type: Article
Times cited : (57)

References (47)
  • 1
    • 34250020201 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis
    • El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576.
    • (2007) Gastroenterology , vol.132 , pp. 2557-2576
    • El-Serag, H.B.1    Rudolph, K.L.2
  • 2
    • 63049133092 scopus 로고    scopus 로고
    • Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005
    • Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009; 27: 1485-1491.
    • (2009) J Clin Oncol , vol.27 , pp. 1485-1491
    • Altekruse, S.F.1    McGlynn, K.A.2    Reichman, M.E.3
  • 3
    • 84873902214 scopus 로고    scopus 로고
    • Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients
    • Cucchetti A, Cescon M, Trevisani F, et al. Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients. World J Gastroenterol 2012; 18: 6398-6408.
    • (2012) World J Gastroenterol , vol.18 , pp. 6398-6408
    • Cucchetti, A.1    Cescon, M.2    Trevisani, F.3
  • 4
    • 0036189111 scopus 로고    scopus 로고
    • Prognostic prediction and treatment strategy in hepatocellular carcinoma
    • Jordi B, Josep ML. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519-524.
    • (2002) Hepatology , vol.35 , pp. 519-524
    • Jordi, B.1    Josep, M.L.2
  • 5
    • 0036096420 scopus 로고    scopus 로고
    • Hepatocellular carcinoma: Diagnosis and treatment
    • Befeler AS, Di Bisceglie AM. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609-1619.
    • (2002) Gastroenterology , vol.122 , pp. 1609-1619
    • Befeler, A.S.1    Di Bisceglie, A.M.2
  • 6
    • 0027458323 scopus 로고
    • Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma
    • Ikeda E, Saitoh S, Tsubota A, et al. Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma. Cancer 1993; 71: 19-25.
    • (1993) Cancer , vol.71 , pp. 19-25
    • Ikeda, E.1    Saitoh, S.2    Tsubota, A.3
  • 7
    • 79751492851 scopus 로고    scopus 로고
    • NF-κB in the liver - linking injury, fibrosis and hepatocellular carcinoma
    • Luedde T, Schwabe RF. NF-κ B in the liver - linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol 2011; 8: 108-118.
    • (2011) Nat Rev Gastroenterol Hepatol , vol.8 , pp. 108-118
    • Luedde, T.1    Schwabe, R.F.2
  • 8
    • 4644324186 scopus 로고    scopus 로고
    • NF-κB functions as a tumour promoter in inflammation-associated cancer
    • Pikarsky E, Porat RM, Stein I, et al. NF-κ B functions as a tumour promoter in inflammation-associated cancer. Nature 2004; 431: 461-466.
    • (2004) Nature , vol.431 , pp. 461-466
    • Pikarsky, E.1    Porat, R.M.2    Stein, I.3
  • 9
    • 0035139792 scopus 로고    scopus 로고
    • Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer
    • Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-κ B pathway in the treatment of inflammation and cancer. J Clin Invest 2001; 107: 135-142.
    • (2001) J Clin Invest , vol.107 , pp. 135-142
    • Yamamoto, Y.1    Gaynor, R.B.2
  • 10
    • 12144289400 scopus 로고    scopus 로고
    • Aphysical and functional map of the human TNFα/NF-κ B signal transduction pathway
    • Bouwmeester T, BauchA, Ruffner H, et al. Aphysical and functional map of the human TNFα/NF-κ B signal transduction pathway. Nat Cell Biol 2004; 6: 97-105.
    • (2004) Nat Cell Biol , vol.6 , pp. 97-105
    • Bouwmeester, T.1    Bauch, A.2    Ruffner, H.3
  • 11
    • 0037044575 scopus 로고    scopus 로고
    • The Iκ B- NF-κ B signaling module: Temporal control and selective gene activation
    • Hoffmann A, Levchenko A, Scott ML, et al. The Iκ B- NF-κ B signaling module: temporal control and selective gene activation. Science 2002; 298: 1241-1245.
    • (2002) Science , vol.298 , pp. 1241-1245
    • Hoffmann, A.1    Levchenko, A.2    Scott, M.L.3
  • 12
    • 54049155149 scopus 로고    scopus 로고
    • C-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor-α (TNFα)-induced NF-κB activation
    • Varfolomeev E, Goncharov T, Fedorova AV, et al. c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor-α (TNFα)-induced NF-κ B activation. J Biol Chem 2008; 283: 24295-24299.
    • (2008) J Biol Chem , vol.283 , pp. 24295-24299
    • Varfolomeev, E.1    Goncharov, T.2    Fedorova, A.V.3
  • 13
    • 85047692516 scopus 로고    scopus 로고
    • Aggarwal. Signalling pathways of the TNF superfamily: A double-edged sword
    • Bharat B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003; 3: 745-756.
    • (2003) Nat Rev Immunol , vol.3 , pp. 745-756
    • Bharat, B.1
  • 14
    • 47749089820 scopus 로고    scopus 로고
    • Regulation of TNFR1 and CD95 signalling by receptor compartmentalization
    • Schütze S, Tchikov V, Wulf SB. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008; 9: 655-662.
    • (2008) Nat Rev Mol Cell Biol , vol.9 , pp. 655-662
    • Schütze, S.1    Tchikov, V.2    Wulf, S.B.3
  • 15
    • 0025266685 scopus 로고
    • Activation in vitro of NF-κ B by phosphorylation of its inhibitor IκB
    • Ghosh S, Baltimore D. Activation in vitro of NF-κ B by phosphorylation of its inhibitor Iκ B. Nature 1990; 344: 678-682.
    • (1990) Nature , vol.344 , pp. 678-682
    • Ghosh, S.1    Baltimore, D.2
  • 16
    • 39949085247 scopus 로고    scopus 로고
    • IKKã (NEMO) is involved in the coordination of the AP-1 and NF-κ B pathways
    • Shifera AS, Friedman JM, Horwitz MS. IKKã (NEMO) is involved in the coordination of the AP-1 and NF-κ B pathways. Mol Cell Biochem 2008; 310: 181-190.
    • (2008) Mol Cell Biochem , vol.310 , pp. 181-190
    • Shifera, A.S.1    Friedman, J.M.2    Horwitz, M.S.3
  • 17
    • 0037593903 scopus 로고    scopus 로고
    • Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated anti-apoptotic activity of nerve growth factor in breast cancer cells
    • El YI, Adriaenssens E, Dolle L, et al. Tumor necrosis factor receptor-associated death domain protein is involved in the neurotrophin receptor-mediated anti-apoptotic activity of nerve growth factor in breast cancer cells. J Biol Chem 2003; 278: 16952-16956.
    • (2003) J Biol Chem , vol.278 , pp. 16952-16956
    • El, Y.I.1    Adriaenssens, E.2    Dolle, L.3
  • 18
    • 0033636538 scopus 로고    scopus 로고
    • Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway
    • Tsao DH, McDonagh T, Telliez JB, et al. Solution structure of N-TRADD and characterization of the interaction of N-TRADD and C-TRAF2, a key step in the TNFR1 signaling pathway. Mol Cell 2000; 5: 1051-1057.
    • (2000) Mol Cell , vol.5 , pp. 1051-1057
    • Tsao, D.H.1    McDonagh, T.2    Telliez, J.B.3
  • 19
    • 84859072803 scopus 로고    scopus 로고
    • Signal transduction by tumor necrosis factor receptors
    • Cabal-Hierro L, Lazo PS. Signal transduction by tumor necrosis factor receptors. Cell Signal 2012; 24: 1297-1305.
    • (2012) Cell Signal , vol.24 , pp. 1297-1305
    • Cabal-Hierro, L.1    Lazo, P.S.2
  • 20
    • 33646034316 scopus 로고    scopus 로고
    • Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO
    • Ea CK, Deng L, Xia ZP, et al. Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO. Mol Cell 2006; 22: 245-257.
    • (2006) Mol Cell , vol.22 , pp. 245-257
    • Ea, C.K.1    Deng, L.2    Xia, Z.P.3
  • 21
    • 77953923379 scopus 로고    scopus 로고
    • Sphingosine-1-phosphate is amissing cofactor for the E3 ubiquitin ligase TRAF2
    • Alvarez SE, Harikumar KB,Hait NC, et al. Sphingosine-1-phosphate is amissing cofactor for the E3 ubiquitin ligase TRAF2. Nature 2010; 465: 1084-1088.
    • (2010) Nature , vol.465 , pp. 1084-1088
    • Alvarez, S.E.1    Harikumar, K.B.2    Hait, N.C.3
  • 22
    • 67649500009 scopus 로고    scopus 로고
    • GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer
    • Scott KL, Kabbarah O, LiangMC, et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 2009; 459: 1085-1090.
    • (2009) Nature , vol.459 , pp. 1085-1090
    • Scott, K.L.1    Kabbarah, O.2    Liang, M.C.3
  • 23
    • 84864452759 scopus 로고    scopus 로고
    • Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor
    • Zeng ZL, Lin H, Zhao XH, et al. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin Cancer Res 2012; 18: 4059-4069.
    • (2012) Clin Cancer Res , vol.18 , pp. 4059-4069
    • Zeng, Z.L.1    Lin, H.2    Zhao, X.H.3
  • 24
    • 84865053189 scopus 로고    scopus 로고
    • GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer
    • Li H, Guo L, Chen SW, et al. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically N0 oral tongue cancer. J Transl Med 2012; 10: 168.
    • (2012) J Transl Med , vol.10 , pp. 168
    • Li, H.1    Guo, L.2    Chen, S.W.3
  • 25
    • 84866512281 scopus 로고    scopus 로고
    • Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
    • Hua X, Yu L, Pan W, et al. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 2012; 7: 127.
    • (2012) Diagn Pathol , vol.7 , pp. 127
    • Hua, X.1    Yu, L.2    Pan, W.3
  • 26
    • 79953166050 scopus 로고    scopus 로고
    • Isolation of primary human hepatocytes from normal and diseased liver tissue: A one hundred liver experience
    • Bhogal RH, Hodson J, Bartlett DC, et al. Isolation of primary human hepatocytes from normal and diseased liver tissue: a one hundred liver experience. PLoS One 2011; 6: e18222.
    • (2011) PLoS One , vol.6 , pp. e18222
    • Bhogal, R.H.1    Hodson, J.2    Bartlett, D.C.3
  • 27
    • 0035913278 scopus 로고    scopus 로고
    • TAK1 is a ubiquitin-dependent kinase of MKK and IKK
    • Wang C, Deng L, Hong M, et al. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 2001; 412: 346-351.
    • (2001) Nature , vol.412 , pp. 346-351
    • Wang, C.1    Deng, L.2    Hong, M.3
  • 28
    • 0034568260 scopus 로고    scopus 로고
    • GMx33: A novel family of trans-Golgi proteins identified by proteomics
    • Wu CC, Taylor RS, Lane DR, et al. GMx33: a novel family of trans-Golgi proteins identified by proteomics. Traffic 2000; 1: 963-975.
    • (2000) Traffic , vol.1 , pp. 963-975
    • Wu, C.C.1    Taylor, R.S.2    Lane, D.R.3
  • 29
    • 70349835304 scopus 로고    scopus 로고
    • GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding
    • Dippold HC, Ng MM, Farber-Katz SE, et al. GOLPH3 bridges phosphatidylinositol-4-phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 2009; 139: 337-351.
    • (2009) Cell , vol.139 , pp. 337-351
    • Dippold, H.C.1    Ng, M.M.2    Farber-Katz, S.E.3
  • 30
    • 84920723013 scopus 로고    scopus 로고
    • An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation
    • Isaji T, Im S, Gu W, et al. An oncogenic protein Golgi phosphoprotein 3 up-regulates cell migration via sialylation. J Biol Chem 2014; 17: 229-237.
    • (2014) J Biol Chem , vol.17 , pp. 229-237
    • Isaji, T.1    Im, S.2    Gu, W.3
  • 31
    • 84866512281 scopus 로고    scopus 로고
    • Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer
    • Hua X, Yu L, Pan W, et al. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 2012; 7: 127.
    • (2012) Diagn Pathol , vol.7 , pp. 127
    • Hua, X.1    Yu, L.2    Pan, W.3
  • 32
    • 84919845478 scopus 로고    scopus 로고
    • High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma
    • Hu GS, Li YQ, Yang YM, et al. High expression of Golgi phosphoprotein-3 is associated with poor survival in patients with hepatocellular carcinoma. Tumour Biol 2014; 35: 8625-8632.
    • (2014) Tumour Biol , vol.35 , pp. 8625-8632
    • Hu, G.S.1    Li, Y.Q.2    Yang, Y.M.3
  • 33
    • 84906066890 scopus 로고    scopus 로고
    • GOLP3 is a predictor of survival in patients with hepatocellular carcinoma
    • JianXin J, Cha Y, ZhiPeng L, et al. GOLP3 is a predictor of survival in patients with hepatocellular carcinoma. Clin Invest Med 2014; 37: E233.
    • (2014) Clin Invest Med , vol.37 , pp. E233
    • JianXin, J.1    Cha, Y.2    ZhiPeng, L.3
  • 34
    • 0033020416 scopus 로고    scopus 로고
    • Role of α-fetoprotein in the diagnosis and management of hepatocellular carcinoma
    • Philip J. Role of α-fetoprotein in the diagnosis and management of hepatocellular carcinoma. J Gastroenterol Hepatol 1999; 14: 32-36.
    • (1999) J Gastroenterol Hepatol , vol.14 , pp. 32-36
    • Philip, J.1
  • 35
    • 33947204625 scopus 로고    scopus 로고
    • Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma
    • Jia HL, Ye QH, Qin LX, et al. Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma. Clin Cancer Res 2007; 13: 1133-1139.
    • (2007) Clin Cancer Res , vol.13 , pp. 1133-1139
    • Jia, H.L.1    Ye, Q.H.2    Qin, L.X.3
  • 36
    • 84880592164 scopus 로고    scopus 로고
    • New progress of non-surgical treatments for hepatocellular carcinoma
    • Cheng JW, Lv Y. New progress of non-surgical treatments for hepatocellular carcinoma. Med Oncol 2013; 30: 381.
    • (2013) Med Oncol , vol.30 , pp. 381
    • Cheng, J.W.1    Lv, Y.2
  • 37
    • 0023200184 scopus 로고
    • A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study
    • Falkson G, Ryan LM, Johnson LA, et al. A random phase II study of mitoxantrone and cisplatin in patients with hepatocellular carcinoma. An ECOG study. Cancer 1987; 60: 2141-2145.
    • (1987) Cancer , vol.60 , pp. 2141-2145
    • Falkson, G.1    Ryan, L.M.2    Johnson, L.A.3
  • 38
    • 0028862265 scopus 로고
    • Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours
    • Ellis PA, Norman A, Hill A, et al. Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours. Eur J Cancer 1995, 31A: 1594-1598.
    • (1995) Eur J Cancer , vol.31 A , pp. 1594-1598
    • Ellis, P.A.1    Norman, A.2    Hill, A.3
  • 39
    • 70349171689 scopus 로고    scopus 로고
    • The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma
    • Sung WS. The current practice of transarterial chemoembolization for the treatment of hepatocellular carcinoma. Korean J Radiol 2009; 10: 425-434.
    • (2009) Korean J Radiol , vol.10 , pp. 425-434
    • Sung, W.S.1
  • 40
    • 33749261599 scopus 로고    scopus 로고
    • Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
    • Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006; 242: 151-167.
    • (2006) Cancer Lett , vol.242 , pp. 151-167
    • Pang, R.1    Poon, R.T.2
  • 41
    • 47949116252 scopus 로고    scopus 로고
    • Sorafenib in advanced hepatocellular carcinoma
    • Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390.
    • (2008) N Engl J Med , vol.359 , pp. 378-390
    • Llovet, J.M.1    Ricci, S.2    Mazzaferro, V.3
  • 42
    • 44849117768 scopus 로고    scopus 로고
    • Akt-dependent regulation of NF-κ B is controlled by mTOR and Raptor in associationwith IKK
    • Dan HC, Cooper MJ, Cogswell PC, et al. Akt-dependent regulation of NF-κ B is controlled by mTOR and Raptor in associationwith IKK. Genes Dev 2008; 22: 1490-1500.
    • (2008) Genes Dev , vol.22 , pp. 1490-1500
    • Dan, H.C.1    Cooper, M.J.2    Cogswell, P.C.3
  • 43
    • 0037379425 scopus 로고    scopus 로고
    • Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2
    • Shi ST, Lee KJ, Aizaki H, et al. Hepatitis C virus RNA replication occurs on a detergent-resistant membrane that cofractionates with caveolin-2. J Virol 2003; 77: 4160-4168.
    • (2003) J Virol , vol.77 , pp. 4160-4168
    • Shi, S.T.1    Lee, K.J.2    Aizaki, H.3
  • 44
    • 79952322370 scopus 로고    scopus 로고
    • Inhibitors of endoplasmic reticulum α-glucosidases potently suppress hepatitis C virus virion assembly and release
    • Qu X, Pan X, Weidner J, et al. Inhibitors of endoplasmic reticulum α-glucosidases potently suppress hepatitis C virus virion assembly and release. Antimicrob Agents Chemother 2011; 55: 1036-1044.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 1036-1044
    • Qu, X.1    Pan, X.2    Weidner, J.3
  • 45
    • 84865037783 scopus 로고    scopus 로고
    • Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion
    • Bishé B, Syed GH, Field SJ, et al. Role of phosphatidylinositol 4-phosphate (PI4P) and its binding protein GOLPH3 in hepatitis C virus secretion. J Biol Chem 2012; 287: 27637-27647.
    • (2012) J Biol Chem , vol.287 , pp. 27637-27647
    • Bishé, B.1    Syed, G.H.2    Field, S.J.3
  • 46
    • 33750466230 scopus 로고    scopus 로고
    • Introduction to NF-κ B: Players, pathways, perspectives
    • Gilmore TD. Introduction to NF-κ B: players, pathways, perspectives. Oncogene 2006; 25(51): 6680-6684.
    • (2006) Oncogene , vol.25 , Issue.51 , pp. 6680-6684
    • Gilmore, T.D.1
  • 47
    • 0033595892 scopus 로고    scopus 로고
    • The Rel/NF-κ B signal transduction pathway: Introduction
    • Gilmore TD. The Rel/NF-κ B signal transduction pathway: introduction. Oncogene 1999; 18: 6842-6844.
    • (1999) Oncogene , vol.18 , pp. 6842-6844
    • Gilmore, T.D.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.